Ventria Bioscience Competitors and Similar CompaniesClear all
Sosei Heptares's competitors and similar companies include GBT (Global Blood Therapeutics).
 GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. | ||
Founding Date | Founding Date 1990 | Founding Date 2012 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Tokyo, JP HQ Dublin, IE Cambridge, GB London, GB | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB |
Employees | Employees 387 | Employees 352106% increase |
Valuation ($) | Valuation ($) 697 m | Valuation ($) 4.4 b |
Financial | ||
Revenue (est.) | Revenue (est.) ¥29.6b (FY, 2025) | Revenue (est.) $194.7m (FY, 2021) |
Cost of goods | Cost of goods ¥7.3b (FY, 2025) | Cost of goods $3.3m (FY, 2021) |
Net income | Net income (¥12.5b) (FY, 2025) | Net income ($303.1m) (FY, 2021) |
Funding | ||
Total funding raised | Total funding raised $ 65m | Total funding raised $ 88.7m |
For sources of this data, please see the company profile
View Company Profiles
GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View company